Skip to main content
OpenTrials
Completed

NCT Number: NCT03956732

Effects of Milk Protein and Vitamin D on Children's Growth and Health

The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–8 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Nutrition, Exercise and Sports, University of Copenhagen

Frederiksberg, Denmark

About this study

The D-pro study investigates the effects of high or medium intakes of milk protein, and vitamin D supplements or placebo, in healthy 6-8 year-old Danish children. The study is a 2×2-factorial randomized controlled trial with 4 study arms. The subjects will be randomly allocated to receive yoghurt products with either high or medium protein content (300g/day, 6 days/week) and to receive tablets with either vitamin D (20 μg/day) or placebo for 24 weeks. Measurements and biological sampling will be performed at baseline and at the end of the intervention.

The primary outcome will be bone mineral density (BMD). The investigators will also measure effects on children's muscle function, cardiometabolic health, body composition, growth and growth factors, nutrient status, immune defence and risk of acute respiratory tract infections, as well as appetite hormones. The investigators will also assess potential sex-specific effects and the potential modifying effect of genotype.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children must:

  • Be 6-8 years of age at the start of the intervention
  • Be healthy
  • Have a frequent intake of milk and yoghurt products, corresponding to at least ¼ liter a day
  • Like yoghurt and high protein yoghurt ("skyr")
  • Be of white, Danish or European origin

Moreover:

  • The family must not be planning a winter vacation south of a latitude of 50° North
  • The child must speak and understand Danish in order to understand the study procedures
  • At least one parent must read, speak and write Danish

Exclusion criteria

  • Known or suspected allergy or intolerance to milk or milk components
  • Chronic illness or disease that may affect study outcomes
  • Chronic intake of medicine that may affect study outcomes
  • Use of vitamin D-containing supplements >3 days/week the 2 last months and use of any vitamin D-containing supplements the last 1 month before intervention start
  • Concomitant participation in other studies involving dietary supplements or blood sampling
  • Living in a household with another participating child

Treatment and study plan

Milk Protein (high)

Dietary Supplement

High protein yoghurt which contains approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.

Vitamin D

Dietary Supplement

One daily tablet containing 20 μg of vitamin D3, cholecalciferol.

Milk Protein (medium)

Dietary Supplement

Ordinary yoghurt containing approx. 3.3 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.

Primary outcomes

  1. Bone Mineral Density (BMD)

    Time frame: 24 weeks

    Measured by dual energy x-ray absorptiometry (DXA)

Secondary outcomes

  1. Bone Mineral Content (BMC)

    Time frame: 24 weeks

    by DXA

  2. Fat mass index

    Time frame: 24 weeks

    by DXA

  3. Fat free mass index

    Time frame: 24 weeks

    by DXA

  4. Bone area

    Time frame: 24 weeks

    by DXA

  5. Height

    Time frame: 24 weeks

    by stadiometer

  6. Waist circumference

    Time frame: 24 weeks

  7. Insulin-like Growth Factor 1 (IGF-1)

    Time frame: 24 weeks

    by fasting blood sample

  8. Insulin-like growth factor-binding protein 3 (IGFBP-3)

    Time frame: 24 weeks

    by fasting blood sample

  9. Serum calcium

    Time frame: 24 weeks

    by fasting blood sample

  10. Osteocalcin

    Time frame: 24 weeks

    by fasting blood sample

  11. Parathyroid hormone (PTH)

    Time frame: 24 weeks

    by fasting blood sample

  12. Bone-specific alkaline phosphatase

    Time frame: 24 weeks

    by fasting blood sample

  13. C-terminal telopeptide of type 1 collagen in serum (s-CTX)

    Time frame: 24 weeks

    by fasting blood sample

  14. Maximal leg press strength

    Time frame: 24 weeks

    Measured by isometric leg press

  15. Maximal jumping height

    Time frame: 24 weeks

    Measured by squat jump with linear encoder

  16. Maximal jumping length

    Time frame: 24 weeks

    Measured by standing long jump

  17. Maximal grip strength

    Time frame: 24 weeks

    Measured by hand grip dynamometer

  18. Muscle endurance

    Time frame: 24 weeks

    Measured by 30 sec. sit-to-stand

  19. Blood pressure

    Time frame: 24 weeks

  20. Hemoglobin A1c (HbA1c)

    Time frame: 24 weeks

    by fasting blood sample

  21. Glucose

    Time frame: 24 weeks

    by fasting blood sample

  22. Insulin

    Time frame: 24 weeks

    by fasting blood sample

  23. Total cholesterol

    Time frame: 24 weeks

    by fasting blood sample

  24. High density lipoprotein cholesterol (HDL cholesterol)

    Time frame: 24 weeks

    by fasting blood sample

  25. Low density lipoprotein cholesterol (LDL cholesterol)

    Time frame: 24 weeks

    by fasting blood sample

  26. Triacylglycerol (TG)

    Time frame: 24 weeks

    by fasting blood sample

Other outcomes

  1. Physical activity

    Time frame: 24 weeks

    by accelerometry

  2. C-peptide

    Time frame: 24 weeks

    by fasting blood sample

  3. Vitamin D binding protein

    Time frame: 24 weeks

    by fasting blood sample

  4. Serum 25(OH) vitamin D

    Time frame: 24 weeks

    by fasting blood sample

  5. 1,25(OH)2vitamin D

    Time frame: 24 weeks

    by fasting blood sample

  6. Urea

    Time frame: 24 weeks

    by fasting blood sample

  7. Interleukin-6 (IL-6)

    Time frame: 24 weeks

    by fasting blood sample

  8. Interleukin-1β (IL-1β)

    Time frame: 24 weeks

    by fasting blood sample

  9. Tumor necrosis factor a (TNF-a)

    Time frame: 24 weeks

    by fasting blood sample

  10. Leptin

    Time frame: 24 weeks

    by fasting blood sample

  11. Adiponectin

    Time frame: 24 weeks

    by fasting blood sample

  12. High sensitivity C-reactive protein (hsCRP)

    Time frame: 24 weeks

    by fasting blood sample

  13. Immune cell counts

    Time frame: 24 weeks

    by fasting blood sample

  14. Immuno-active peptides in nasal fluid

    Time frame: 24 weeks

    by nasal fluid sample

  15. Immuno-active peptides in blood

    Time frame: 24 weeks

    by fasting blood sample

  16. Respiratory tract infections

    Time frame: 24 weeks

    by questionnaires

  17. Dietary intake

    Time frame: 24 weeks

    By 4-day dietary record

  18. Vitamin D and calcium intake

    Time frame: 24 weeks

    By food frequency questionnaire

Sponsors and collaborators

Lead sponsor

University of Copenhagen

Other

Collaborators

  • Arla Foods
  • University of Aarhus

Registry information

Official study title

Effects of Milk Protein and Vitamin D on Children's Growth and Health (D-pro)

Acronym: D-pro

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
May 21, 2019
Registry last updated
Apr 15, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.